Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a phone app help cannabis users beat stress and cut back?

NCT ID NCT06085222

Disease control Sponsor: Florida State University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Sep 02, 2026 · Updated 2 times

Summary

This study tests a brief computerized and smartphone-based program designed to help regular cannabis users with Cannabis Use Disorder better handle emotional stress. The goal is to see if the intervention reduces distress intolerance and cannabis use compared to a health education program. Eighty participants will be followed for four months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
behavioral intervention (computerized distress tolerance training with smartphone support)
What this could lead to
If successful, this could provide a low-cost, accessible tool to help people with Cannabis Use Disorder manage stress and reduce their cannabis use.
What could go wrong
This is an early-stage trial with only 80 participants, so results may not apply broadly. The intervention is behavioral and may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 80 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2024

Expected to finish

Jan 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 30 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Cannabis is the primary substance of abuse. * Clinical-level Distress intolerance Index score. * Current Cannabis Use Disorder diagnosis. * Near-daily to daily cannabis use in past-month and past 3 months. * Positive urine screen for THC * Detectable skin conductance level * Owns a smart phone * Primary smoked/vaporized delta-9 or delta-8 THC user Exclusion Criteria: * Presence of acute/major psychiatric disturbance * Current pregnancy * Change in psychotropic medication within the past month * Concurrently receiving treatment for cannabis use * Concurrently receiving dialectical behavior therapy or exposure-based therapy for emotional disorders * Planning to immediately quit using cannabis * EEG contraindications * Kidney disease

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cannabis use disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cannabis dependence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cannabis use disorder

Contacts and locations

Locations

  • The BRAINS Lab at Florida State University

    Tallahassee, Florida, 32306-4301, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.